Actively Recruiting
Autoimmune Hepatitis Cohort in China
Led by Shanghai Jiao Tong University School of Medicine · Updated on 2023-03-28
1000
Participants Needed
1
Research Sites
260 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to describe the clinical features and long-term prognosis in patients diagnosed with autoimmune hepatitis (AIH) in China and assess the effectiveness and safety of AIH treatment options in a real-world setting.
CONDITIONS
Official Title
Autoimmune Hepatitis Cohort in China
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 14 years or older
- Probable or definite autoimmune hepatitis diagnosis based on International Autoimmune Hepatitis Study Group criteria
- Availability of key lab tests at initial AIH diagnosis including alanine transaminase, aspartate aminotransferase, total bilirubin, alkaline phosphatase, immunoglobulin G, and platelet count
- Provide informed consent
You will not qualify if you...
- Diagnosis of primary biliary sclerosis, primary sclerosing cholangitis, or immunoglobulin G4-related cholangitis
- Active infection with hepatitis B virus, hepatitis C virus, hepatitis delta virus, HIV, cytomegalovirus, or Epstein-Barr virus
- Diagnosis of hepatocellular carcinoma or other malignant diseases before AIH diagnosis
- Considered ineligible for enrollment by the researcher
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality, China, 200001
Actively Recruiting
Research Team
X
Xiao Xiao, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here